MYSTERIOUS: Crl | Mind Blowing Facts

Is Charles River Laboratories Stock Outperforming the S&P 500?

Charles River Laboratories has outperformed the broader market over the past year, while analysts remain bullish on the company’s outlook.

Barchart · Sep 27

Is Wall Street Bullish or Bearish on Charles River Laboratories Stock?

Charles River Laboratories has significantly outperformed the market, while strong guidance and a bullish analyst outlook support continued optimism.

Barchart · Aug 26

Charles River Laboratories Earnings Preview: What to Expect

Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company’s bottom-line figure.

Barchart · Jul 20

What Are Wall Street Analysts' Target Price for Charles River Laboratories Stock?

Charles River Laboratories has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart · Feb 20

What to Expect From Charles River Laboratories’ Next Quarterly Earnings Report

Charles River Laboratories is scheduled to report its fiscal fourth-quarter results shortly, with analysts forecasting a low–double-digit year-over-year decline in earnings.

Barchart · Jan 19

Is Charles River Laboratories Stock Underperforming the Dow?

Despite lagging the Dow Jones Industrial Average over the past year, Charles River Laboratories continues to attract cautious optimism from analysts regarding its longer-term outlook.

Barchart · Dec 16, 2025

Charles River Laboratories Stock: Is Wall Street Bullish or Bearish?

Charles River Laboratories has continued to underperform the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

Barchart · Nov 21, 2025

Charles River Beat Expectations But Why Is The Stock Falling?

Charles River Laboratories International Inc. (NYSE:CRL) stock is trading lower on Wednesday after the company released third-quarter 2025 earnings. It also provided an update on the company’s strategic review.

Benzinga · Nov 5, 2025

What to Expect From Charles River Laboratories' Q3 2025 Earnings Report

Charles River Laboratories is all set to release its fiscal third-quarter earnings next month, and analysts project a low double-digit profit decline.

Barchart · Oct 23, 2025

Is Charles River Laboratories Stock Underperforming the Nasdaq?

Charles River Laboratories has significantly underperformed the Nasdaq Composite over the past year, yet analysts remain cautiously optimistic about the stock’s prospects.

Barchart · Sep 24, 2025